Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting

On April 12, 2016 Heat Biologics, Inc. ("Heat") (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, reported three poster presentations at the AACR (Free AACR Whitepaper) Annual Meeting, including initial preclinical results from Heat’s collaboration with OncoSec Medical Incorporated, a biotechnology company developing DNA-based intra-tumoral cancer immunotherapies (Press release, Heat Biologics, APR 12, 2016, View Source [SID:1234510679]). The AACR (Free AACR Whitepaper) Annual Meeting is being held on April 16-20, 2016 in New Orleans, LA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The details for the poster presentations at the AACR (Free AACR Whitepaper) Annual Meeting are as follows:

Title: In vivo intra-tumoral electroporation of Gp96-Ig/Fc-OX40L stimulates CD8+ T cell cross-priming to tumor specific neoantigens
Date and Time: April 17, 2016 at 1:00 p.m. – 5:00 p.m. CT
Location: Section 26
Session Title: Immune Modulating Agents 1
Abstract ID: 567

Title: Vesigenurtacel-L stimulates tumor infiltration of unique polyclonal T cell clones in non-muscle invasive bladder cancer patients
Date and Time: April 18, 2016 at 8:00 a.m. – 12:00 p.m. CT
Location: Section 22
Session Title: Immune Response Monitoring: Clinical
Abstract ID: 1405

Title: Combination immunotherapy: T cell costimulation (OX40L, TL1A, 4-1BBL and ICOSL) secreted locally by Gp96-Ig vaccines, elicits robust antigen-specific, memory T cell responses and tumor elimination
Date and Time: April 18, 2016 at 1:00 – 5:00 p.m. CT
Location: Section 27
Session Title: Therapeutic Antibodies and Vaccines
Abstract ID: 2353

Copies of the abstracts are available and can be viewed online through the AACR (Free AACR Whitepaper) website at www.aacr.org. Posters will be uploaded to the Publications section of Heat’s corporate website upon completion of the sessions to abide by the conference’s embargo policy.